In the News

Eko Secures FDA Clearance for Heart Disease Detection Software

Use of EMAS algorithm will enable healthcare professionals to identify valvular heart disease.
July 13, 2022

Digital health company Eko has received US Food and Drug Administration (FDA) clearance for its Cloud-based machine learning algorithm Eko Murmur Analysis Software (EMAS).

The software characterises heart murmurs by assessing heart sounds, phonocardiogram and ECG signals (when available) captured using Eko’s smart stethoscopes.

Read more at Medical Device Network